Physician profile
David Lin
NPI 1558333476
$19,958.47
in general payments reported to CMS, 2019-2025
17 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,237 · 2020: $236 · 2021: $186 · 2022: $720 · 2023: $184 · 2024: $16K · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $899 · Travel and Lodging: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,000.00 |
| Food and Beverage | $898.60 |
| Travel and Lodging | $681.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossio INC | $16,144.56 | 2023-2024 | |
| Seapearl East, INC | $1,569.68 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $433.12 | 2022-2023 | |
| Arthrex, INC. | $360.32 | 2019-2025 | |
| Depuy Synthes Sales INC. | $252.37 | 2020-2022 | |
| Vb Spine LLC | $242.01 | 2025 | Lite Bio Delivery System |
| Miach Orthopaedics, INC. | $188.37 | 2022 | |
| Orthofix Medical, INC. | $163.40 | 2021 | |
| Biomarin Pharmaceutical INC. | $140.64 | 2019-2022 | |
| Abbott Laboratories | $125.16 | 2024-2025 | Proclaim, Ensite Precision |
| Orthopediatrics Corp. | $108.22 | 2024-2025 | |
| Gramercy Extremity Orthopedics LLC | $78.00 | 2020 | |
| Stryker Corporation | $69.81 | 2024 | Variax, Inspace |
| Kairos Surgical INC | $37.43 | 2023 | |
| Abiomed | $22.73 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $14.59 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.06 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.